This is not the most recent version of the article. View current version (7 FEB 2014)

Intervention Protocol

Mycophenolate mofetil for relapsing-remitting multiple sclerosis

  1. Yousheng Xiao1,
  2. Jianyi Huang1,
  3. Hongye Luo2,
  4. Jin Wang1,*

Editorial Group: Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group

Published Online: 14 NOV 2012

Assessed as up-to-date: 15 AUG 2012

DOI: 10.1002/14651858.CD010242


How to Cite

Xiao Y, Huang J, Luo H, Wang J. Mycophenolate mofetil for relapsing-remitting multiple sclerosis (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD010242. DOI: 10.1002/14651858.CD010242.

Author Information

  1. 1

    The First Affiliated Hospital, Guangxi Medical University, Department of Neurology, Nanning, Guangxi, China

  2. 2

    Guangxi Medical University, Department of Epidemiology & Statistics, Nanning, Guangxi, China

*Jin Wang, Department of Neurology, The First Affiliated Hospital, Guangxi Medical University, No. 22, Shuang Yong Lu, Nanning, Guangxi, 530021, China. wangjin72@126.com.

Publication History

  1. Publication Status: New
  2. Published Online: 14 NOV 2012

SEARCH

This is not the most recent version of the article. View current version (07 FEB 2014)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To investigate the effects and safety on disease activity of MMF for patients with relapsing-remitting MS.